Home
Cancer Clinical Trials
28
TMB-High
Cancer Clinical Trials
Tumor-Agnostic Precision Immuno-Oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study
A Study to Evaluate Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)
A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioblastoma With Elevated Mutational Burden
A Study Evaluating Targeted Therapies in Participants Who Have Advanced Solid Tumors With Genomic Alterations or Protein Expression Patterns Predictive of Response
A Modular Multi-Basket Trial to Improve Personalized Medicine in Cancer Patients (Basket of Baskets)
Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)
The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy
CRAFT: The NCT-PMO-1602 Phase II Trial
A Study of Targeted Agents With Atezolizumab for Patients With Recurrent or Persistent Endometrial Cancer
Nivolumab in Patients With IDH-Mutant Gliomas With and Without Hypermutator Phenotype